Want to stay updated on the latest news?
Create a Reader Account today to follow the industries and companies that interest you, and customize your news dashboard. SIGN INTO READER ACCOUNT CREATE READER ACCOUNT
ClearPoint Neuro annonce un accord de licence exclusif pluriannuel avec l'UCSF concernant une plateforme innovante pour l'administration cellulaire intracérébrale
March 28, 2023 17:57 ET
|
ClearPoint Neuro, Inc.
SOLANA BEACH, Californie, 28 mars 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ : CLPT) (la « Société »), une société mondiale de plateformes thérapeutiques permettant la navigation et...
ClearPoint Neuro gibt exklusive mehrjährige Lizenzvereinbarung mit UCSF für innovative intrazerebrale Zellverabreichungsplattform bekannt
March 28, 2023 17:57 ET
|
ClearPoint Neuro, Inc.
SOLANA BEACH, Kalifornien, March 28, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) (das „Unternehmen“), ein weltweites Unternehmen für therapieermöglichende Plattformen, das die...
Rumble Launches Supporter Badges & Monthly Subscriptions
March 28, 2023 17:54 ET
|
Rumble, Inc.
LONGBOAT KEY, Fla., March 28, 2023 (GLOBE NEWSWIRE) -- Rumble, the video-sharing platform (NASDAQ: RUM), announced today the launch of Supporter Badges and Monthly Subscriptions. Users now have new...
Safe Harbor Financial to Hold Fourth Quarter and Full Year 2022 Earnings Conference Call on Thursday, March 30, 2023
March 28, 2023 17:52 ET
|
Safe Harbor Financial Services, Inc.
GOLDEN, Colo., March 28, 2023 (GLOBE NEWSWIRE) -- SHF Holdings, Inc., d/b/a/ Safe Harbor Financial (“Safe Harbor” or the “Company”) (NASDAQ: SHFS), a leader in facilitating banking, payments, and...
GreenLight Biosciences Announces Fourth Quarter and Full Year 2022 Financial Results
March 28, 2023 17:05 ET
|
GreenLight Biosciences
Two agriculture solutions now under regulatory review, pending EPA approval: Calantha™, a solution to protect potatoes, and a separate solution to protect honeybees from Varroa miteUpdated clinical...
Precipio Announces 2022 Fourth Quarter and Year-End Shareholder Update Call
March 28, 2023 17:00 ET
|
Precipio, Inc.
NEW HAVEN, Conn., March 28, 2023 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be hosting its Q4-2022 and year end shareholder update call on Monday,...
Maravai LifeSciences Releases 2022 Environmental, Social and Governance (ESG) Report
March 28, 2023 17:00 ET
|
Maravai LifeSciences Holdings LLC
- Highlights progress across five priority areas focused on building a foundation for sustainable growth. - Reports Scope 1 and Scope 2 greenhouse gas emissions. - Maravai advances Diversity, Equity...
Eloxx Pharmaceuticals Announces Submission of Investigational New Drug (IND) Application for ZKN-013
March 28, 2023 16:45 ET
|
Eloxx Pharmaceuticals
ZKN-013 in development for treatment of recessive dystrophic epidermolysis bullosa (RDEB) and junctional epidermolysis bullosa (JEB) Additional IND filing for ZKN-013 for treatment of familial...
Mereo BioPharma Reports Full Year 2022 Financial Results and Recent Highlights
March 28, 2023 16:30 ET
|
Mereo BioPharma Group plc
LONDON, March 28, 2023 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO) (“Mereo” or the “Company”), a clinical-stage biopharmaceutical company focused on rare diseases, today announced...
Adagene Reports Full Year 2022 Financial Results and Provides Corporate Update
March 28, 2023 16:30 ET
|
Adagene Inc.
- Clinical data for wholly-owned anti-CTLA-4 franchise show best-in-class safety profiles for unmasked and masked candidates, unlocking the full therapeutic benefit of anti-CTLA-4 in combination with...